Tag: Dr. Reddy’s Labs

Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio

businessnewstoday- February 28, 2023

Dr. Reddy's Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an Australian pharma company, in a deal worth ... Read More

Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate

pallavi123- July 30, 2022

Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic ... Read More

Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US

pallavi123- August 5, 2021

Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare’s Aleve, in the ... Read More

Dr. Reddy’s launches Sputnik V Covid vaccine in India at Rs 995 per dose

pallavi123- May 14, 2021

Dr. Reddy's Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad. The ... Read More

PRESECO clinical trial for Avigan : Appili begins dosing in phase 3 Covid-19 study

pharmanewsdaily- December 3, 2020

Appili Therapeutics said that it has dosed the first participant in the phase 3 PRESECO clinical trial for Avigan tablets (favipiravir) for the oral treatment ... Read More